文献速递重症综合管理与镇静镇痛呼吸衰竭与机械通气

微血栓是新型冠状病毒肺炎严重程度的主要病理机制吗?——尸检病理发现的系统评价

Is Microthrombosis the Main Pathology in Coronavirus Disease 2019 Severity?-A Systematic Review of the Postmortem Pathologic Findings.
PubMed 文献 · Crit Care Explor · 2021-05-20
一句话结论系统评价尸检显示弥漫性肺泡损伤最常见,肺微血栓与血管新生广泛存在,作者认为需关注抗凝治疗。

该系统评价检索2019年12月1日至2020年8月26日PubMed、Excerpta Medica Database和Cochrane图书馆文献,筛选360篇唯一参考文献,最终纳入65项符合条件的研究、共691例完成尸检的新型冠状病毒肺炎死亡患者。肺部组织病理学评估显示,443例中323例存在弥漫性肺泡损伤,326例中242例存在肺微血栓;在评估血栓栓塞事件的尸检中,深静脉血栓和肺栓塞分别占41%和约15%。重症患者D-二聚体水平普遍较高,非存活者铁蛋白、乳酸脱氢酶、白细胞介素-6和C反应蛋白水平高于存活者。作者结论认为肺微血栓和肺血管广泛新生是肺部最常见病理发现,微血栓见于多数评估的器官组织。

要点

  • 691例尸检中,肺部弥漫性肺泡损伤最常见:443例中323例存在。
  • 肺微血栓在326例中242例存在,是肺部主要病理发现之一。
  • 评估血栓栓塞事件的尸检中,深静脉血栓占41%,肺栓塞约占15%。
  • 重症患者D-二聚体水平普遍较高;非存活者铁蛋白、乳酸脱氢酶、白细胞介素-6和C反应蛋白高于存活者。
  • 作者认为肺微血栓和血管新生与疾病特异性高凝状态一致,需关注抗凝治疗。

适用人群与场景

  • 死于新型冠状病毒肺炎并接受尸检评估的患者,纳入65项研究共691例完成尸检。

研究设计与关键结果

  • 系统评价纳入65项研究、691例完成尸检的新型冠状病毒肺炎死亡患者。
  • 肺部组织病理学评估:443例中323例存在弥漫性肺泡损伤。
  • 肺部组织病理学评估:326例中242例存在肺微血栓。
  • 在评估血栓栓塞事件的尸检中,深静脉血栓占41%,肺栓塞约占15%。
  • 重症临床病程患者D-二聚体水平普遍较高。
  • 非存活者血浆铁蛋白、乳酸脱氢酶、白细胞介素-6和C反应蛋白水平高于存活者。
  • 总体而言,肺微血栓和肺血管广泛新生是肺部最常见病理发现,微血栓见于多数评估的器官组织。

证据类型、等级与局限

  • 证据类型:系统评价(尸检病理研究汇总)。
  • 检索数据库:PubMed、Excerpta Medica Database、Cochrane图书馆,时间2019年12月1日至2020年8月26日。
  • 筛选360篇唯一参考文献,最终纳入65项符合条件的研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,新型冠状病毒肺炎患者中广泛的肺微血栓、肺血管新生及频发的肺内外微血栓和血栓栓塞发现,似乎与疾病特异性高凝状态一致。
  • 作者认为,需进一步研究评估新型冠状病毒肺炎、高凝状态与免疫血栓形成之间的联系。
  • 作者认为,在此期间需要增加对新型冠状病毒肺炎患者抗凝治疗方案的关注。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

UNLABELLED: This systematic review attempts to retrieve and report the findings of postmortem studies including the histopathologic data of deceased coronavirus disease 2019 patients and to review the manifestations of coronavirus disease 2019-associated thrombotic pathologies reported in the recent literature.

DATA SOURCES: PubMed, Excerpta Medica Database, and Cochrane library between December 1, 2019, and August 26, 2020.

STUDY SELECTION: Investigators screened 360 unique references, retrieved published autopsy series, and report on the postmortem histopathologic information on patients who had died of coronavirus disease 2019.

DATA EXTRACTION: Investigators independently abstracted all available data including study design, participant demographics, key histopathologic findings, disease severity markers, duration of hospital stay, and cause of death.

DATA SYNTHESIS: From the 65 eligible studies, 691 total completed autopsies were included in evidence synthesis. Histopathologic evaluation of the lungs revealed presence of diffuse alveolar damage in 323 of 443 patients and pulmonary microthrombi in 242 of 326 patients. Deep venous thrombosis and pulmonary embolism were found in 41% and ~15%, respectively, of the cadavers examined for thromboembolic events. d-dimer levels were generally higher in patients with severe clinical course of coronavirus disease 2019. Plasma levels of ferritin, lactate dehydrogenase, interleukin-6, and C-reactive protein were higher in nonsurvivors when compared with survivors. Overall, microthrombi and extensive angiogenesis of lung vasculature were the most common pathologic findings in the lungs and microthrombi in most of the assessed organ-tissue.

CONCLUSIONS: Diffuse alveolar damage was the most predominant feature in the lungs of coronavirus disease 2019 patients who underwent postmortem assessment. Widespread pulmonary microthrombosis and extensive pulmonary angiogenesis, in addition to frequent pulmonary and extrapulmonary microthrombotic and thromboembolic findings in patients with coronavirus disease 2019, appear to be consistent with the disease-specific hypercoagulability. Further discovery efforts in assessing the link between coronavirus disease 2019, hypercoagulable state, and immunothrombosis are warranted. In the interim, increased attention to anticoagulant treatment approaches in coronavirus disease 2019 patients is needed.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Fahmy OH, Daas FM, Salunkhe V, et al. Is Microthrombosis the Main Pathology in Coronavirus Disease 2019 Severity?-A Systematic Review of the Postmortem Pathologic Findings. Crit Care Explor. 2021. PMID: 34036278. doi:10.1097/CCE.0000000000000427

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。